GlaxoSmithKline PLC — Director's Dealing 2015

Feb 20, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4896F

GlaxoSmithKline PLC

20 February 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 20 February 2015 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 19 February 2015, at a price of $47.03 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:

Director/PDMR	Number of ADSs
Mr W C Louv	27
Dr M M Slaoui	20

Connected person	Number of ADSs
Dr K Slaoui (connected person of Dr M M Slaoui)	17

V A Whyte

Company Secretary

20 February 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSFBLFLELFEBBE